From Research Labs to Clinical Products
Date of publication: March 1st, 2017
This product is no longer in stock
|Date of publication||March 1st, 2017|
Since the first images obtained in 2000, Photoacoustic Imaging has raised more and more interest for biomedical and medical applications. First applications were found in Research and Development. A lot of Proofs of Concept for in vitro and in vivo diagnostics and monitoring have been established.
Currently, PAI is spreading to biomedical and medical markets. The 3 main segments are:
In 2016, the total PAI biomedical and medical market was worth $ 35M, due to the Pre-clinical and Analytics segments only. It is forecasted to reach around $ 240M in 2022. A sharp increase is expected starting from 2018, due to the release of clinical products that are to be approved in 2017, like the « Imagio » system from Seno Medical Instruments, US (already CE marked, pending FDA approval). Within 4 to 5 years, the clinical market is expected to become the largest segment of the PAI biomedical and medical market, ahead of Pre-clinical applications. The main applications that will benefit from PAI clinical products are cancer diagnostic, cardiovascular diseases, dermatology, brain imaging, therapy monitoring and drug developments.
In the report, each segment of the PAI market (R&D, Pre-clinical, Analytics and Clinical) is analyzed in detail. Market forecasts and perspectives up to 2022 are provided. Main players are listed and detailed.
In healthcare and life science, there is a huge demand for high resolution imaging at high penetration depth, in real time and at an affordable price. With an appropriate combination of optical and acoustical means, added to data processing and specific algorithms, Photoacoustic Imaging offers several advantages over other biomedical and medical imaging modalities:
In view of all those assets, one can wonder whether PAI could replace other techniques like X-rays for various major imagery applications like breast cancer detection and screening.
The report provides an overview of optical and acoustic technologies forming a PAI system, as well as the trends in data processing and image reconstruction algorithms. It describes in details the main features of PAI, that makes it a powerful technique for clinical applications.
Four implementations of PAI are possible, making it a tool that easily adapts to the clinical need :
PAI is thus expected to be adopted in various clinical applications. However, the access to the clinical market is long and complex. One of the challenges is the acceptation of PAI by clinicians. To overcome this challenge, first clinical devices expected to be adopted are systems combining Ultra-sounds and PAI. Indeed, Ultrasonography (US) is a well-known and well-established technique. However, it provides only structural information. PAI brings functional information to US imaging. Moreover, the entry of PAI into clinical applications is going to be boosted by the growing number of companies - startups and large firms like Fujifilm or Canon - that are investing in this technology.
In the report, we point out the remaining challenges for clinical adoption of PAI, the issues to overcome to get a large imaging market share and a roadmap of the forthcoming clinical product.
AcousticMedsystems, AcousysBiodevices, ActuatedMedical, Advanced Optowave, AlpinionMedical, AnalogicUltrasound, Blatek, BK Medical, Cephasonics, Canon, Cobolt, Continuum, Crystalaser, CTS, Echofos, Echolase, Edgewave, Elforlight , Ekspla, Endra Life Science, Esaote, Fairway Medical Technologies, Fujifilm, G.E. Healthcare, Hitachi Aloka, Hitachi Medical, Hologic, IB Lasers, Illumisonics, Imasonic, Innolas, Innolume, IPG, Japan Probes, Jenoptics, Kolo, Kibero, Laser Export Co, LDX Optronics, Ligth Age, Litron, Lotis TII, Microscopic Photo Acoustics, Multiwave, Omicron, Opotek, OptoSonics, Panametrics, PA Imaging, Philips Research N.A., Koninklijke Philips N.V., Photonics Industries, Photosound, PolarOnyx, PrecisionAcoustic, Prexion, Prosonic, Quantel, Quanta system, S-Sharp, Samsung Medison, Schimadzu, SenoMedical Instruments, Siemens Healthcare, Sirah, Sonaxis, Sonic, Sonotec, SpectraPhysics, Supersonic Imagine, Symphotics TII, TeemPhotonics, TomowaveLaboratories, Ultrasonix, Verasonics, Vermon, Vibronix, VisualSonics, Xarion Laser Acoustics, Zonare.
2. Highlights of the report
3. PAI, a powerful imaging modality
4. PAI technologies overview
5. Markets and Trends
6. Patents Landscape